(15055961), I. A., (15055964), S. K. K., (15055967), X. W., (15055970), J. P., (15055973), Y. W., (15055976), J. R. W., . . . (15056018), S. J. F. (2025). Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL.
Dyfyniad Arddull Chicago(15055961), Ibrahim Aldoss, et al. Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL. 2025.
Dyfyniad MLA(15055961), Ibrahim Aldoss, et al. Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL. 2025.